tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of David Risinger, 138 are a BUY (52.08%), 108 are a HOLD (40.75%), 19 are a SELL (7.17%).
Analyst David Risinger, currently employed at LEERINK, carries an average stock price target met ratio of 74.21% that have a potential upside of 20.64% achieved within 303 days.
David Risinger’s has documented 505 price targets and ratings displayed on 32 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on HALO, Halozyme Therapeutics at 13-Oct-2025.
Analyst best performing recommendations are on BHC (BAUSCH HEALTH COMPANIES).
The best stock recommendation documented was for ALKS (ALKERMES PLC) at 1/21/2016. The price target of $35 was fulfilled within 1 day with a profit of $1.31 (3.89%) receiving and performance score of 38.88.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$242
$14.01 (6.15%)
$216
9 days ago
(19-Oct-2025)
27/28 (96.43%)
$9.94 (4.28%)
437
Buy
$250
$22.01 (9.65%)
$220
12 days ago
(16-Oct-2025)
13/14 (92.86%)
$20.43 (8.90%)
399
Buy
$284
$56.01 (24.57%)
$220
19 days ago
(09-Oct-2025)
43/44 (97.73%)
$53.5 (23.21%)
593
Hold
$251
$23.01 (10.09%)
$205
26 days ago
(02-Oct-2025)
15/16 (93.75%)
$17.09 (7.31%)
300
Buy
$270
$42.01 (18.43%)
$195
1 months 12 days ago
(16-Sep-2025)
2/3 (66.67%)
$49.19 (22.28%)
121
Which stock is David Risinger is most bullish on?
Which stock is David Risinger is most reserved on?
What Year was the first public recommendation made by David Risinger?
